Olga Pirogova Sells 548 Shares of Azenta, Inc. (NASDAQ:AZTA) Stock

Azenta, Inc. (NASDAQ:AZTA) SVP Olga Pirogova sold 548 shares of Azenta stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total transaction of $21,958.36. Following the completion of the transaction, the senior vice president now owns 19,373 shares in the company, valued at approximately $776,276.11. This trade represents a 2.75 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Azenta Trading Up 2.0 %

Shares of NASDAQ AZTA traded up $0.88 during trading hours on Thursday, hitting $45.53. The stock had a trading volume of 1,347,000 shares, compared to its average volume of 513,855. The firm’s 50-day moving average price is $45.32 and its two-hundred day moving average price is $50.22. Azenta, Inc. has a 52 week low of $38.82 and a 52 week high of $69.16.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 earnings per share. On average, research analysts predict that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Azenta

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. bought a new stake in shares of Azenta during the 2nd quarter worth $30,000. Farther Finance Advisors LLC lifted its position in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after acquiring an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its position in shares of Azenta by 150.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares during the last quarter. Lazard Asset Management LLC bought a new position in shares of Azenta in the first quarter worth about $130,000. Finally, Acadian Asset Management LLC lifted its position in shares of Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after purchasing an additional 471 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Ratings Changes

AZTA has been the topic of several analyst reports. Evercore ISI dropped their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Needham & Company LLC dropped their target price on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Azenta presently has a consensus rating of “Hold” and a consensus price target of $63.60.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.